12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Other News

Allergan endocrine/metabolic news

Allergan disclosed in its 3Q12 earnings that it is exploring strategic options for its obesity intervention business, including...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >